The Overuse of Painkillers in India

India is witnessing a concerning rise in the overuse of painkillers, particularly opioids like tapentadol and tramadol. A national survey revealed that approximately 2.1% of the Indian population aged 10–75 used opioids in the past year, with around 7.7 million individuals meeting criteria for opioid use disorders. In cities like Bengaluru, the National Institute of Mental Health and Neurosciences (NIMHANS) reported a sharp increase in tapentadol addiction cases, rising from 15–20 annually in 2018 to 15–20 monthly in recent years. Similarly, in Hyderabad, easy access to painkillers without prescriptions has led to growing concerns among medical experts about rising addiction rates among youth. The trend reflects a deeper issue of inadequate pain management education, loose pharmaceutical regulations, and a lack of awareness about the long-term impact of drug dependency.

The implications of this trend are multifaceted and increasingly alarming. Prolonged and unsupervised use of painkillers can lead to severe health complications, including liver and kidney damage, gastrointestinal bleeding, cardiovascular issues, and even fatal overdoses. Psychologically, users may develop dependence and tolerance, requiring higher doses for the same relief, which fuels the addiction cycle. Furthermore, indiscriminate consumption often masks the root causes of chronic pain, delaying proper diagnosis and treatment. The societal cost is also significant—addiction impacts workplace productivity, increases the burden on healthcare systems, and affects family dynamics. Experts stress the urgent need for public awareness campaigns, tighter pharmaceutical regulations, and greater accessibility to mental health resources. Promoting integrative approaches like cognitive-behavioral therapy, physiotherapy, and holistic wellness practices can help curb this growing dependency and create a more informed, health-conscious society.